Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors
- 1 June 2000
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 20 (11) , 3817-3830
- https://doi.org/10.1128/mcb.20.11.3817-3830.2000
Abstract
The class II phosphoinositide 3-kinases (PI3K) PI3K-C2α and PI3K-C2β are two recently identified members of the large PI3K family. Both enzymes are characterized by the presence of a C2 domain at the carboxy terminus and, in vitro, preferentially utilize phosphatidylinositol and phosphatidylinositol 4-monophosphate as lipid substrates. Little is understood about how the catalytic activity of either enzyme is regulated in vivo. In this study, we demonstrate that PI3K-C2α and PI3K-C2β represent two downstream targets of the activated epidermal growth factor (EGF) receptor in human carcinoma-derived A431 cells. Stimulation of quiescent cultures with EGF resulted in the rapid recruitment of both enzymes to a phosphotyrosine signaling complex that contained the EGF receptor and Erb-B2. Ligand addition also induced the appearance of a second, more slowly migrating band of PI3K-C2α and PI3K-C2β immunoreactivity on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Since both PI3K enzymes can utilize Ca2+ as an essential divalent cation in lipid kinase assays and since the catalytic activity of PI3K-C2α is refractory to the inhibitor wortmannin, these properties were used to confirm the recruitment of each PI3K isozyme to the activated EGF receptor complex. To examine this interaction in greater detail, PI3K-C2β was chosen for further investigation. EGF and platelet-derived growth factor also stimulated the association of PI3K-C2β with their respective receptors in other cells, including epithelial cells and fibroblasts. The use of EGF receptor mutants and phosphopeptides derived from the EGF receptor and Erb-B2 demonstrated that the interaction with recombinant PI3K-C2β occurs through E(p)YL/I phosphotyrosine motifs. The N-terminal region of PI3K-C2β was found to selectively interact with the EGF receptor in vitro, suggesting that it mediates the association of this PI3K with the receptor. However, the mechanism of this interaction remains unclear. We conclude that class II PI3K enzymes may contribute to the generation of 3′ phosphoinositides following the activation of polypeptide growth factor receptors in vivo and thus mediate certain aspects of their biological activity.Keywords
This publication has 78 references indexed in Scilit:
- Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimersThe EMBO Journal, 1998
- Cloning and Characterization of a Novel Class II Phosphoinositide 3-Kinase Containing C2 DomainBiochemical and Biophysical Research Communications, 1998
- Identification and cDNA Cloning of a Novel Mammalian C2 Domain-Containing Phosphoinositide 3-Kinase, HsC2-PI3KBiochemical and Biophysical Research Communications, 1997
- Subsets of Epidermal Growth Factor Receptors during Activation and EndocytosisPublished by Elsevier ,1997
- Binding to the Platelet-derived Growth Factor Receptor Transiently Activates the p85α-p110α Phosphoinositide 3-Kinase Complex in VivoJournal of Biological Chemistry, 1996
- Cpk Is a Novel Class of Drosophila PtdIns 3-Kinase Containing a C2 DomainPublished by Elsevier ,1996
- A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transductionCurrent Biology, 1995
- SH2 domains recognize specific phosphopeptide sequencesPublished by Elsevier ,1993
- Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinasesCell, 1991
- Anti-phosphotyrosine immunoprecipitation of phosphatidylinositol 3′ kinase activity in different cell types after exposure to epidermal growth factorBiochemical and Biophysical Research Communications, 1990